system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: OBJECTIVE, METHODS, METHODS, METHODS, METHODS, METHODS, RESULTS. Meshes: Animals, Dextromethorphan, Disease Models, Animal, Dopamine, Drug Administration Schedule, Female, Hyperprolactinemia, Hypothalamus, Injections, Subcutaneous, Lactation, Morphine, Pituitary Gland, Pregnancy, Prolactin, Rats, Rats, Sprague-Dawley, Time Factors, Up-Regulation.
user
Does coadministration of dextromethorphan during pregnancy and throughout lactation prevent morphine-induced hyperprolactinemia in female rats? Context: To investigate whether coadministration of dextromethorphan (DM) could suppress morphine-induced hyperprolactinemia in female rats during pregnancy and throughout lactation. Controlled prospective study. University research laboratory. One hundred adult female Sprague-Dawley rats. Rats were randomly divided into four groups and were subcutaneously injected with either saline, morphine, morphine + DM, or DM alone twice a day, progressively increasing by 1 mg/kg at 7-day intervals from an initial dose of 2 mg/kg for both morphine and DM. Drug administration was continued during pregnancy. After the offspring were born, the doses injected into the dams were increased by 1 mg/kg every 2 weeks. Serum prolactin (PRL) concentration and dopamine turnover rate at the hypothalamus and pituitary. Chronic morphine administration induced higher PRL concentrations than the control animals at mating, and at early and late pregnancy. In rats receiving DM coadministration, we did not observe any increase by morphine. Our neurochemical results showed that this effect of DM may be partly through blocking the effect of morphine on inhibition of tuberoinfundibular dopaminergic (TIDA) neuronal activity.
assistant
The use of DM as an adjuvant in females receiving chronic morphine treatment may prevent morphine-induced hyperprolactinemia. Final Decision: yes